Newsroom | 12231 results

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar to Present at Jefferies Global Healthcare Conference on November 19, 2025...

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that its Board of Directors has declared a quarterly cash dividend of $0.01 per share of common stock. The dividend is payable on Jan. 2, 2026, to stockholders of record as of Nov. 28, 2025. The indicated annual dividend rate equates to $0.04 per share of common stock. “As we previously announced in conjunction with third-quarter 2025 earnings, we will be reducing the quarterly divid...

DUBLIN--(BUSINESS WIRE)--The "Tendinopathy Market - A Global and Regional Analysis: Focus on Treatment and Region - Analysis and Forecast, 2025-2035" has been added to ResearchAndMarkets.com's offering. The global tendinopathy market is experiencing notable expansion, driven by the increasing prevalence of musculoskeletal disorders, heightened awareness about the condition, and advancements in pharmacological, regenerative, and biologic therapies. As the incidence of tendinopathy continues to r...

ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem to Participate at 16th Annual Craig-Hallum Alpha Select Conference on November 18, 2025...

TOKYO--(BUSINESS WIRE)--Kaneka Corporation (siège social : Minato-ku, Tokyo ; président : Kazuhiko Fujii) (TOKYO : 4118) a commencé à commercialiser son i-ED COIL™, une spirale d’embolisation pour anévrisme cérébral (*1), en Europe depuis octobre. Le produit a obtenu la certification CE (*2) en vertu du règlement européen sur les dispositifs médicaux (*3) en juillet et sera distribué principalement en Europe par Kaneka Medical Europe N.V. Le produit i-ED COIL™ offre une flexibilité de classe mo...

TOKIO--(BUSINESS WIRE)--Die Kaneka Corporation (Hauptsitz: Minato-ku, Tokio; Präsident: Kazuhiko Fujii) (TOKYO:4118) hat im Oktober mit dem Verkauf seiner i-ED COIL™, einer Embolisationsspule zur Behandlung von zerebralen Aneurysmen (*1), in Europa begonnen. Das Produkt hat im Juli die EU-Zertifizierung (*2) nach einer EU-Medizinprodukteverordnung (*3) erhalten und wird hauptsächlich in Europa durch Kaneka Medical Europe N.V. vertrieben. Die i-ED COIL™ bietet eine Flexibilität von Weltklasse, d...

TOKIO--(BUSINESS WIRE)--Kaneka Corporation (sede central: Minato-ku, Tokio; presidente: Kazuhiko Fujii) (TOKIO: 4118) empieza a comercializar en Europa su espiral de embolización de aneurismas cerebrales (*1) i-ED COIL™ a partir de octubre. El producto obtuvo en julio la certificación CE (*2) en virtud del Reglamento sobre productos sanitarios de la UE (*3) y se distribuirá principalmente en Europa a través de Kaneka Medical Europe N.V. El i-ED COIL™ ofrece una flexibilidad de primer nivel, gra...

TOKYO--(BUSINESS WIRE)--Kaneka Corporation (sede centrale: Minato-ku, Tokyo; presidente: Kazuhiko Fujii) (TOKYO:4118) ha iniziato a ottobre in Europa la vendita di i-ED COIL™ – una spirale per l’embolizzazione di aneurismi cerebrali (*1) – che lo scorso luglio ha ottenuto la certificazione CE (*2) ai sensi del Regolamento europeo sui dispositivi medici (*3) e sarà distribuita principalmente in Europa tramite Kaneka Medical Europe N.V. i-ED COIL™ offre un livello di flessibilità ineguagliato gra...

TOKIO--(BUSINESS WIRE)--Kaneka Corporation (hoofdkantoor: Minato-ku, Tokio; president: Kazuhiko Fujii) (TOKYO:4118) is in oktober begonnen met de verkoop van zijn i-ED COIL™, een embolisatiecoil voor hersenaneurysma's (*1), in Europa. Het product heeft in juli de EC-certificering (*2) gekregen onder de EU-verordening voor medische hulpmiddelen (*3) en zal voornamelijk in Europa worden gedistribueerd via Kaneka Medical Europe N.V. De i-ED COIL™ biedt flexibiliteit van wereldklasse, dankzij de sp...

DULUTH, Ga.--(BUSINESS WIRE)--National Vision Holdings, Inc. (NASDAQ: EYE) (“National Vision” or the “Company”), will host an Investor Day on Monday, November 17, 2025, in New York City, as previously announced. The event, to be held at the NASDAQ MarketSite in Times Square, will highlight the Company’s transformation strategies and financial outlook, featuring a series of presentations as well as a question-and-answer session with members of the Company’s senior leadership team, including Alex...